Jaklenec Group's News

August 20, 2024

We are pleased to welcome two new Associate Editors to ACS Nano: Dr. Ana Jaklenec, a principal research scientist and principal investigator at the David H. Koch Institute for Integrative Cancer Research at MIT...

July 9, 2024

Jaklenec and Langer teamed up with the Bill & Melinda Gates Foundation to work on a strategy to fight malnutrition, which affects more than 735 million people worldwide...

June 16, 2024

Postdoc, Erika Wang, was awarded the Student and Young Investigator (SYIS) Scientific Excellence Award at the TERMIS World Congress recognizing her top-rated abstract submission on drug delivery!

June 11, 2024

Award-winning KI Images creators Jooli Han and Linzixuan (Rhoda) Zhang present on their image, "The Golden Monument: New Heights for Global Health." Jaklenec and Langer Lab technologies can administer multiple vaccine doses with a...

June 3, 2024

The Jaklenec Group attended the first-ever AIMBE Regional Event hosted by Boston University! Local fellows showcased innovations from BU, Harvard, MIT, Northeastern, and Tufts. Dr. Ana Jaklenec and P.h.D. student, Rhoda Zhang, presented new possibilities and equity...

March 8, 2024

Numerous vaccines, such as those for whooping cough and hepatitis B, contain bits of bacterial or viral proteins. These vaccines also often contain adjuvants, which are molecules that help enhance the response of the immune system to the...

March 8, 2024

Researchers from the Massachusetts Institute of Technology (MIT) have revealed that a new type of nanoparticle could be used to improve the delivery and immune responses of vaccines...

March 7, 2024

In a landmark breakthrough, scientists at the Massachusetts Institute of Technology have unveiled a pioneering approach to vaccine development with the potential to reshape the landscape of preventive medicine...

March 7, 2024

Zeolitic imidazolate frameworks boost SARS-CoV-2 spike protein trimer immunity via Toll-like receptor activation...

March 6, 2024

Study shows metal-organic particles can both deliver vaccines and act as an adjuvant to generate a strong immune response at a lower dose...